Interestingly, increased expression of AKR1B10 was observed in NASH patients compared with NAFL, while FABP5 expression was consistently increased as the disease progresses compared with healthy obese patients (Figure 6A,B). Here, FABP5 is linked to metabolic dysfunction-associated steatohepatitis.